Newsroom

NEW
DxI 9000 Access Immunoassay Analyzer

Featured News

Beckman Coulter’s DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.’s Annual Supplier Innovation Celebration

 

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the DxI 9000 Immunoassay Analyzer* was honored during Premier, Inc.’s annual supplier Innovation Celebration at its 2024 Breakthroughs Conference and Exhibition. The Innovation Celebration recognizes groundbreaking healthcare technologies that have been launched throughout the year and the ways these products are helping to improve the health of communities.

Read more

News Releases

Learn more about the latest news and happenings at Beckman Coulter. 

See all news releases  


  • May 7, 2024

    Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics

    Read more
  • April 16, 2024 

    Beckman Coulters DxI 9000 Immunoassay Analyzer Extends Menu with New CE-Marked Hepatitis Assays at ESCMID Global

    Read more
  • March 12, 2024 

    Beckman Coulter and Fujirebio Expand Partnership to Develop Patient- friendly, Blood-based Neurodegenerative Disease Diagnostics

    Read more
  • February 6, 2024

    Beckman Coulter Appoints Kevin O'Reilly as New President

    Read more
Global Public Relations
Name Jeff Tarmy
Address Beckman Coulter World Headquarters
Brea California
Phone +1-617-467-7537

Stay Connected